XML 42 R31.htm IDEA: XBRL DOCUMENT v3.23.3
Description of Business, Basis of Presentation and Going Concern (Detail) - USD ($)
$ / shares in Units, $ in Thousands
9 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Organization Consolidation And Presentation Of Financial Statements [Line Items]    
Retained earnings (accumulated deficit) $ (281,192) $ (265,524)
Cash and cash equivalent $ 8,238 $ 12,126
Class A Common Stock    
Organization Consolidation And Presentation Of Financial Statements [Line Items]    
Common stock par value (in usd per share) $ 0.01 $ 0.01
Class A Common Stock | Cantor Fitzgerald    
Organization Consolidation And Presentation Of Financial Statements [Line Items]    
Remaining available stock value $ 37,300  
Class A Common Stock | LPC Purchase Agreement    
Organization Consolidation And Presentation Of Financial Statements [Line Items]    
Common stock, capital shares reserved for future issuance (in shares) 9,437,376  
Class B Common Stock    
Organization Consolidation And Presentation Of Financial Statements [Line Items]    
Common stock par value (in usd per share) $ 0.01 $ 0.01
vTv Therapeutics LLC    
Organization Consolidation And Presentation Of Financial Statements [Line Items]    
Percentage of non-voting economic interest of vTv Therapeutics Holdings LLC in vTv LLC 22.10%  
Percentage of non-voting economic interest of vTv Therapeutics Inc in vTv LLC 77.90%  
vTv Therapeutics LLC | Class B Common Stock    
Organization Consolidation And Presentation Of Financial Statements [Line Items]    
Common stock par value (in usd per share) $ 0.01